reglab/statecodes huggingface dataset:
New Mexico Administrative Code › Title 16 - OCCUPATIONAL AND PROFESSIONAL LICENSING › Chapter 17 - OSTEOPATHIC MEDICINE AND SURGERY PRACTITIONERS › Part 8 - PHYSICIANS SUPERVISING PHARMACIST CLINICIANS › Section 16.17.8.2 - SCOPE

Current through Register Vol. 35, No. 13, July 16, 2024
The provisions in Part 9 of Chapter 17 apply to all
				  osteopathic physicians who supervise pharmacist clinicians.
New Mexico Administrative Code › Title 16 - OCCUPATIONAL AND PROFESSIONAL LICENSING › Chapter 17 - OSTEOPATHIC MEDICINE AND SURGERY PRACTITIONERS › Part 8 - PHYSICIANS SUPERVISING PHARMACIST CLINICIANS › Section 16.17.8.3 - STATUTORY AUTHORITY

Current through Register Vol. 35, No. 13, July 16, 2024
These rules of practice and procedure govern the practice of
				  medicine in New Mexico and are promulgated pursuant to and in accordance with
				  the Osteopathic Medicine Act, Section
				  61-10-5
				  1978 and the Pharmacist Prescriptive Authority Act, Subsection B of Sections
				  61-11-1
				  to
				  61-11-3
				  NMSA 1978.
New Mexico Administrative Code › Title 16 - OCCUPATIONAL AND PROFESSIONAL LICENSING › Chapter 17 - OSTEOPATHIC MEDICINE AND SURGERY PRACTITIONERS › Part 8 - PHYSICIANS SUPERVISING PHARMACIST CLINICIANS › Section 16.17.8.5 - EFFECTIVE DATE

Current through Register Vol. 35, No. 13, July 16, 2024
June 11, 2018, unless a later date is cited at the end of a
				  section.
New Mexico Administrative Code › Title 16 - OCCUPATIONAL AND PROFESSIONAL LICENSING › Chapter 17 - OSTEOPATHIC MEDICINE AND SURGERY PRACTITIONERS › Part 8 - PHYSICIANS SUPERVISING PHARMACIST CLINICIANS › Section 16.17.8.6 - OBJECTIVE

Current through Register Vol. 35, No. 13, July 16, 2024
The objective of Part 9 of Chapter 17 is to establish and
				  adopt rules to carry out the board's responsibilities set forth in Section
				  61-11B-1
				  thru 61-11B-3 NMSA 1978, the "Pharmacist Authority Act".
New Mexico Administrative Code › Title 16 - OCCUPATIONAL AND PROFESSIONAL LICENSING › Chapter 17 - OSTEOPATHIC MEDICINE AND SURGERY PRACTITIONERS › Part 8 - PHYSICIANS SUPERVISING PHARMACIST CLINICIANS › Section 16.17.8.7 - DEFINITIONS

Current through Register Vol. 35, No. 13, July 16, 2024
A.
				"
Consultation
" means in person, telephonically, by two-way radio,
				by e-mail or by other electronic means.
B. "
Alternate supervising
				physician
" means a physician who holds a current unrestricted license to
				practice medicine or osteopathic medicine, is a cosignatory on the notification
				of supervision, and agrees to act as the supervising physician in the
				supervising physician's absence with no change to the scope of practice or
				protocol of the pharmacist clinician. The alternate supervising physician must
				be approved by the board. The alternate supervising physician which should
				require the alternate supervising physician to register with the appropriate
				board and shall be exempt from fees associated with the supervising physician
				unless the alternate supervising physician becomes a supervising physician then
				the appropriate fees will be assessed.
C. "
Scope of practice
" means
				duties and limitations of duties placed upon a pharmacist clinician by their
				supervising physician or the alternate supervising physician(s) and the board;
				includes the limitations implied by the field of practice of the supervising
				physician or the alternate supervising physician(s) and the board.
New Mexico Administrative Code › Title 16 - OCCUPATIONAL AND PROFESSIONAL LICENSING › Chapter 17 - OSTEOPATHIC MEDICINE AND SURGERY PRACTITIONERS › Part 8 - PHYSICIANS SUPERVISING PHARMACIST CLINICIANS › Section 16.17.8.8 - APPROVAL OF SUPERVISING PHYSICIANS

Current through Register Vol. 35, No. 13, July 16, 2024
A physician shall only be approved as a pharmacist clinician
				  supervisor after the pharmacist clinician registers with the board by
				  submitting an application for authority to practice under the supervision of a
				  licensed physician. The application shall include:
A. the name, address, phone number of the
				applicant, and proof of current certification as a pharmacist clinician by the
				board of pharmacy;
B. the name,
				address, and phone number of the supervising physician;
C. a written protocol agreed to and signed by
				the pharmacist clinician and the supervising physician that shall include:
(1) a statement identifying the physician
				authorized to prescribe dangerous drugs and the pharmacist clinician who is a
				party to the guidelines or protocol;
(2) a statement of the types of prescriptive
				authority that the pharmacist clinician is authorized to make within his scope
				of practice which may include:
(a) a
				statement of the types of diseases, dangerous drugs or dangerous drug
				categories involved and the type of prescriptive authority authorized in each
				case; and
(b) a general statement
				of the procedures, decision criteria or plan the pharmacist clinician is to
				follow when exercising prescriptive authority;
(c) a statement of the activities the
				pharmacist clinician is to follow in the course of exercising prescriptive
				authority, including documentation of decisions made and a plan for
				communication to and consultation with the supervising physician concerning
				specific decisions made; documentation may occur on the prescriptive record,
				patient profile, patient medical chart or in a separate log book; and
(d) a statement that describes appropriate
				mechanisms for reporting to the physician the pharmacist clinician's activities
				in monitoring the patients; and
(e)
				a statement that describes provisions for immediate communication or
				consultation between the pharmacist clinician and the supervising physician or
				alternate supervising physician.
New Mexico Administrative Code › Title 16 - OCCUPATIONAL AND PROFESSIONAL LICENSING › Chapter 17 - OSTEOPATHIC MEDICINE AND SURGERY PRACTITIONERS › Part 8 - PHYSICIANS SUPERVISING PHARMACIST CLINICIANS › Section 16.17.8.9 - THE PHYSICIAN'S REQUIREMENTS OF SUPERVISION

Current through Register Vol. 35, No. 13, July 16, 2024
A. Supervising physicians must provide
				direction to pharmacist clinicians to specify the pharmacotherapeutic services
				to be provided under the circumstances in each case. This may be done by
				written protocol or by oral consultation. It is the responsibility of the
				supervising physician to assure that the appropriate directions are given and
				understood.
B. Supervising
				physicians must establish a quality assurance program for review of medical
				services provided by the pharmacist clinician.
C. If the supervising physician is of the
				opinion that circumstances warrant exceptions to the requirements set forth in
				Subsections A or B above, the supervising physician must specify the
				circumstances in writing and deliver the same to the board. The board will
				review, grant or deny requests for exceptions or waivers, at the board's
				discretion.
D. Documentation of the
				supervising physician reviews must be retained by the pharmacist clinician and
				be available for board inspection for a period of not less than five years from
				the date of such reviews.
E. The
				pharmacist clinician must have prompt access to the physician by telephone or
				other electronic means for advice and direction.
F. If the supervising physician plans to be
				or is absent from his or her practice for any reason, the supervising physician
				cannot designate a pharmacist clinician to take over those duties or cover the
				practice during such absence. The supervising physician may designate an
				alternate supervising physician, approved by the board, to cover the practice
				and perform the duties of supervising physician. The alternate supervising
				physician will then supervise the pharmacist clinician and will be responsible
				for the pharmacist clinician's actions or omissions in exercising prescriptive
				authority or other duties as a pharmacist clinician.
G. In order to change a supervising physician
				between biennial renewals of registration, without a change to the pharmacist
				clinician's scope of practice or protocol, a pharmacist clinician shall submit
				to the board a change of supervising physician form and the required fee, as
				specified in
				16.10.9.11
				NMAC. The new supervising physician may only act after the application is
				approved by the board.
New Mexico Administrative Code › Title 16 - OCCUPATIONAL AND PROFESSIONAL LICENSING › Chapter 17 - OSTEOPATHIC MEDICINE AND SURGERY PRACTITIONERS › Part 8 - PHYSICIANS SUPERVISING PHARMACIST CLINICIANS › Section 16.17.8.10 - REPORT AND COMMITTEE

Current through Register Vol. 35, No. 13, July 16, 2024
The chair of the board shall appoint two members of the
				  board, or a member and an agent of the board to an oversight committee that
				  shall also include two members appointed by the board of pharmacy. The
				  oversight committee will make a report that may include non-binding
				  recommendations to both the board of pharmacy and the board of osteopathic
				  medical examiners regarding disciplinary action. Each board can accept or
				  reject the recommendations.
New Mexico Administrative Code › Title 16 - OCCUPATIONAL AND PROFESSIONAL LICENSING › Chapter 17 - OSTEOPATHIC MEDICINE AND SURGERY PRACTITIONERS › Part 9 - PHYSICIAN ASSISTANTS: LICENSURE AND PRACTICE REQUIREMENTS › Section 16.17.9.1 - ISSUING AGENCY

Current through Register Vol. 35, No. 13, July 16, 2024
Regulation and Licensing Department - New Mexico Board of
				  Osteopathic Medicine.
New Mexico Administrative Code › Title 16 - OCCUPATIONAL AND PROFESSIONAL LICENSING › Chapter 17 - OSTEOPATHIC MEDICINE AND SURGERY PRACTITIONERS › Part 9 - PHYSICIAN ASSISTANTS: LICENSURE AND PRACTICE REQUIREMENTS › Section 16.17.9.2 - SCOPE

Current through Register Vol. 35, No. 13, July 16, 2024
All licensed osteopathic physician
				  assistants.
New Mexico Administrative Code › Title 16 - OCCUPATIONAL AND PROFESSIONAL LICENSING › Chapter 17 - OSTEOPATHIC MEDICINE AND SURGERY PRACTITIONERS › Part 9 - PHYSICIAN ASSISTANTS: LICENSURE AND PRACTICE REQUIREMENTS › Section 16.17.9.3 - STATUTORY AUTHORITY

Current through Register Vol. 35, No. 13, July 16, 2024
These rules of practice and procedure govern the practice of
				  osteopathic medicine in New Mexico and are promulgated pursuant to and in
				  accordance with the Osteopathic Medicine Act, Section
				  61-10-5
				  NMSA 1978.
New Mexico Administrative Code › Title 16 - OCCUPATIONAL AND PROFESSIONAL LICENSING › Chapter 17 - OSTEOPATHIC MEDICINE AND SURGERY PRACTITIONERS › Part 9 - PHYSICIAN ASSISTANTS: LICENSURE AND PRACTICE REQUIREMENTS › Section 16.17.9.5 - EFFECTIVE DATE

Current through Register Vol. 35, No. 13, July 16, 2024
June 11, 2018, unless a later date is cited at the end of a
				  section.
New Mexico Administrative Code › Title 16 - OCCUPATIONAL AND PROFESSIONAL LICENSING › Chapter 17 - OSTEOPATHIC MEDICINE AND SURGERY PRACTITIONERS › Part 9 - PHYSICIAN ASSISTANTS: LICENSURE AND PRACTICE REQUIREMENTS › Section 16.17.9.6 - OBJECTIVE

Current through Register Vol. 35, No. 13, July 16, 2024
This part regulates the licensing and practice of physician
				  assistants and their supervision by licensed physicians.
New Mexico Administrative Code › Title 16 - OCCUPATIONAL AND PROFESSIONAL LICENSING › Chapter 17 - OSTEOPATHIC MEDICINE AND SURGERY PRACTITIONERS › Part 9 - PHYSICIAN ASSISTANTS: LICENSURE AND PRACTICE REQUIREMENTS › Section 16.17.9.7 - DEFINITIONS

Current through Register Vol. 35, No. 13, July 16, 2024
A. "AAPA" means
				American academy of physician assistants.
B. "Effective supervision" means the exercise
				of physician oversight, control, and direction of services rendered by a
				physician assistant. Elements of effective supervision include:
(1) on-going availability of direct
				communication, either face-to-face, telephonically or by electronic
				means;
(2) active, ongoing review
				of the physician assistant's services, as appropriate, for quality assurance
				and professional support;
(3) a
				predetermined plan for emergency situations; and
(4) identification of other supervising
				physicians, as appropriate to the practice setting.
New Mexico Administrative Code › Title 16 - OCCUPATIONAL AND PROFESSIONAL LICENSING › Chapter 17 - OSTEOPATHIC MEDICINE AND SURGERY PRACTITIONERS › Part 9 - PHYSICIAN ASSISTANTS: LICENSURE AND PRACTICE REQUIREMENTS › Section 16.17.9.8 - QUALIFICATIONS FOR LICENSURE AS A PHYSICIAN ASSISTANT

Current through Register Vol. 35, No. 13, July 16, 2024
A. shall have successfully completed a
				physician assistant program accredited by the:
(1) accreditation review commission on
				education for the physician assistant; or
(2) if prior to January 1, 2001, either the:
(a) committee on accreditation of allied
				health education programs; or
(b)
				committee on allied health education and accreditation;
(c) or its successor agency.
New Mexico Administrative Code › Title 16 - OCCUPATIONAL AND PROFESSIONAL LICENSING › Chapter 17 - OSTEOPATHIC MEDICINE AND SURGERY PRACTITIONERS › Part 9 - PHYSICIAN ASSISTANTS: LICENSURE AND PRACTICE REQUIREMENTS › Section 16.17.9.9 - APPLICATION FOR LICENSURE

Current through Register Vol. 35, No. 13, July 16, 2024
A. A
				completed application for which the applicant has supplied all information and
				correspondence requested by the board on forms and in a manner acceptable to
				the board.
B. Two letters of
				recommendation from physicians licensed to practice medicine in the United
				States or physician assistant program directors, or the director's designee,
				who have personal knowledge of the applicant's moral character and competence
				to practice.
C. Verification of
				licensure in all states where the applicant holds or has held a license to
				practice as a physician assistant, or other health care profession.
				Verification must be sent directly to the board from the other state
				board(s).
D. Verification of all
				work experience in the last two years, if applicable, provided directly to the
				board.
E. All applicants may be
				scheduled for a personal interview before the board or the board's designee and
				must present original documents, as the board requires. The initial license
				will be issued following completion of any required interview, or approval by a
				member or agent of the board.
F.
				License by endorsement from New Mexico medical board. Applicants who are
				currently licensed in good standing by the New Mexico medical board may be
				licensed by endorsement upon receipt of a verification of licensure directly
				from the New Mexico medical board, and a supervising physician form signed by
				the osteopathic physician who will serve as supervising physician.
G. All applicants for licensure who meet the
				requirements for licensure will be granted a temporary license and the license
				will be ratified at its next scheduled meeting.
New Mexico Administrative Code › Title 16 - OCCUPATIONAL AND PROFESSIONAL LICENSING › Chapter 17 - OSTEOPATHIC MEDICINE AND SURGERY PRACTITIONERS › Part 9 - PHYSICIAN ASSISTANTS: LICENSURE AND PRACTICE REQUIREMENTS › Section 16.17.9.10 - BIENNIAL LICENSURE RENEWAL REQUIREMENTS

Current through Register Vol. 35, No. 13, July 16, 2024
A. Before July 1st, the year the license is
				due to expire, all physician assistants must submit an application for renewal
				form provided by the board. Physician assistants who fail to renew their
				certificates as of July 1st, will be subject to suspension of their
				license.
B. Proof of CME upon
				request or audit.
C. Renewal fee
				set forth in
				16.17.2.8
				NMAC.
D. A renewal of licensure
				will be valid for a period of two years and the expiration date will be printed
				on the certificate of licensure.
New Mexico Administrative Code › Title 16 - OCCUPATIONAL AND PROFESSIONAL LICENSING › Chapter 17 - OSTEOPATHIC MEDICINE AND SURGERY PRACTITIONERS › Part 9 - PHYSICIAN ASSISTANTS: LICENSURE AND PRACTICE REQUIREMENTS › Section 16.17.9.11 - APPROVAL OF SUPERVISING PHYSICIANS

Current through Register Vol. 35, No. 13, July 16, 2024
A. A physician may supervise and collaborate
				with no more than three physician assistants and communicate within the
				circumstances of their particular practice setting.
B. All supervising physicians shall submit
				written notice of intent to supervise a physician assistant on forms prescribed
				by the board.
C. Within 30 days
				after an employer terminates the employment of a physician assistant, the
				supervising physician or the physician assistant shall submit a written notice
				to the board providing the date of termination and reason for
				termination.
D. A physician
				assistant who is employed by the United States government and who works on land
				or in facilities owned or operated by the United States government or a
				physician assistant who is a member of the reserve components of the United
				States and on official orders or performing official duties as outlined in the
				appropriate regulation of that branch may be licensed in New Mexico with proof
				that their supervising physician holds an active medical license in another
				state.
New Mexico Administrative Code › Title 16 - OCCUPATIONAL AND PROFESSIONAL LICENSING › Chapter 17 - OSTEOPATHIC MEDICINE AND SURGERY PRACTITIONERS › Part 9 - PHYSICIAN ASSISTANTS: LICENSURE AND PRACTICE REQUIREMENTS › Section 16.17.9.12 - SUPERVISION OF PHYSICIAN ASSISTANT

Current through Register Vol. 35, No. 13, July 16, 2024
Supervision of a physician assistant must be rendered by a
				  licensed supervising physician.
A.
				Responsibility of supervising physician.
(1)
				Provide direction to the physician assistant to specify what medical services
				should be rendered. This may be done through a written utilization plan or by
				other direct communications.
(2)
				Provide a means for immediate communication between the physician assistant and
				the supervising physician.
(3)
				Temporarily delegating supervisory responsibilities to another supervising
				physician during the supervising physician's period of absence.
New Mexico Administrative Code › Title 16 - OCCUPATIONAL AND PROFESSIONAL LICENSING › Chapter 17 - OSTEOPATHIC MEDICINE AND SURGERY PRACTITIONERS › Part 9 - PHYSICIAN ASSISTANTS: LICENSURE AND PRACTICE REQUIREMENTS › Section 16.17.9.13 - SCOPE OF PRACTICE

Current through Register Vol. 35, No. 13, July 16, 2024
A. Unless
				otherwise provided by law, physician assistants may provide medical services
				delegated to them by the supervising physician when such services are within
				the physician assistant's skills and form a usual component of the physician's
				scope of practice.
B. A physician
				assistant may assist a designated supervising physician in an inpatient or
				surgical health care institution within the institution's bylaws or policies
				including act as a first surgical assistant in the performance of surgery, when
				permitted by the institution's bylaws or regulations.
New Mexico Administrative Code › Title 16 - OCCUPATIONAL AND PROFESSIONAL LICENSING › Chapter 17 - OSTEOPATHIC MEDICINE AND SURGERY PRACTITIONERS › Part 9 - PHYSICIAN ASSISTANTS: LICENSURE AND PRACTICE REQUIREMENTS › Section 16.17.9.14 - CONTINUING EDUCATION REQUIREMENTS

Current through Register Vol. 35, No. 13, July 16, 2024
A. If a licensee has been practicing for at
				least two years, and applying for a new license, or upon licensure renewal, 50
				hours of continuing education are required in the preceding two years for
				licensure.
(1) Of the 50 hours, 34 hours must
				be category 1A.
(2) Of the 50
				hours, 30 hours must be in the area in which the physician assistant is
				currently practicing.
New Mexico Administrative Code › Title 16 - OCCUPATIONAL AND PROFESSIONAL LICENSING › Chapter 19 - PHARMACISTS › Part 1 - GENERAL PROVISIONS › Section 16.19.1.3 - STATUTORY AUTHORITY

Current through Register Vol. 35, No. 13, July 16, 2024
The board of pharmacy is authorized under Paragraph (1) of Subsection A of Section 61-11-6 NMSA 1978 to adopt, regularly review and revise rules and regulations necessary to carry out the provisions of the Pharmacy Act, 61-11-1, 61-11-2, 61-11-4 to 61-11-28 NMSA 1978. Paragraph (3) of Subsection A of Section 61-11-6 directs the board to provide for the issuance and renewal of licenses for pharmacists. Paragraphs (12), (13) and (14) of Subsection A of Section 61-11-6 NMSA 1978 directs the board to meet at least once every three months.
New Mexico Administrative Code › Title 16 - OCCUPATIONAL AND PROFESSIONAL LICENSING › Chapter 19 - PHARMACISTS › Part 1 - GENERAL PROVISIONS › Section 16.19.1.5 - EFFECTIVE DATE

Current through Register Vol. 35, No. 13, July 16, 2024
February 15, 1996, unless a different date is cited at the
				  end of a Section or Paragraph. This Part reformatted for inclusion into the New
				  Mexico Administrative Code (NMAC) effective 2-15-96.
New Mexico Administrative Code › Title 16 - OCCUPATIONAL AND PROFESSIONAL LICENSING › Chapter 19 - PHARMACISTS › Part 1 - GENERAL PROVISIONS › Section 16.19.1.6 - OBJECTIVE

Current through Register Vol. 35, No. 13, July 16, 2024
The objective of Part 1 of Chapter 19 is to establish the location for regular meetings of the board, designate persons to preside over board meetings, establish standards for employees and members, and provide for employee job descriptions and a registry of pharmacists.
New Mexico Administrative Code › Title 16 - OCCUPATIONAL AND PROFESSIONAL LICENSING › Chapter 19 - PHARMACISTS › Part 1 - GENERAL PROVISIONS › Section 16.19.1.8 - MEETINGS

Current through Register Vol. 35, No. 13, July 16, 2024
A. The chairman of the board shall preside at all meetings, preserve order, appoint committees and decide all questions of order subject to appeal to the board. In the absence of the chairman, the vice-chairman or a member of the board shall preside. Roberts Rules of Order shall govern all proceedings.
B. Meetings shall be held in the office of the board unless a different location (physical or virtual) is designated by the board.
C. Examinations shall be administered at a place or location specified by the board.
New Mexico Administrative Code › Title 16 - OCCUPATIONAL AND PROFESSIONAL LICENSING › Chapter 19 - PHARMACISTS › Part 1 - GENERAL PROVISIONS › Section 16.19.1.9 - PENALTIES

Current through Register Vol. 35, No. 13, July 16, 2024
As provided in the Uniform Licensing Act, those individuals found to have violated provisions of Subsection A of Section 61-11-20 NMSA 1978 may be fined up to $1,000 for each violation committed plus the cost of the hearing and incurred investigative expenses.
New Mexico Administrative Code › Title 16 - OCCUPATIONAL AND PROFESSIONAL LICENSING › Chapter 19 - PHARMACISTS › Part 1 - GENERAL PROVISIONS › Section 16.19.1.10 - EXECUTIVE DIRECTOR

Current through Register Vol. 35, No. 13, July 16, 2024
The duties and responsibilities of the executive director or
				  any employee of thisboard shall be those which are detailed in the job
				  descriptions filed with the state personnel department.
New Mexico Administrative Code › Title 16 - OCCUPATIONAL AND PROFESSIONAL LICENSING › Chapter 19 - PHARMACISTS › Part 1 - GENERAL PROVISIONS › Section 16.19.1.11 - REGISTRY

Current through Register Vol. 35, No. 13, July 16, 2024
The board shall provide a registry of all persons licensed as pharmacists or pharmacist interns in the state, the board's online license look up system shall satisfy this requirement.
New Mexico Administrative Code › Title 16 - OCCUPATIONAL AND PROFESSIONAL LICENSING › Chapter 19 - PHARMACISTS › Part 1 - GENERAL PROVISIONS › Section 16.19.1.12 - PROTECTED ACTIONS AND COMMUNICATIONS

Current through Register Vol. 35, No. 13, July 16, 2024
A. All written and oral communication made by
				any person to the board or any committee of the board relating to actual or
				potential disciplinary action, which includes complaints made to the board or
				the committee, shall be confidential communications and are not public records
				for the purposes of the Inspection of Public Records Act [Chapter 14, Article 2
				NMSA 1978]. All data, communications and information acquired, prepared or
				disseminated by the board or a committee relating to actual or potential
				disciplinary action or its investigation of complaints shall not be disclosed
				except to the extent necessary to carry out the purposes of the board or the
				committee or in a judicial appeal from the actions of the board or the
				committee or in a referral of cases made to law enforcement agencies, national
				database clearinghouses or other licensing boards.
B. Information contained in complaint files
				is public information and subject to disclosure when the board or the committee
				acts on a complaint and issues a notice of contemplated action or reaches a
				settlement prior to the issuance of a notice of contemplated action.
New Mexico Administrative Code › Title 16 - OCCUPATIONAL AND PROFESSIONAL LICENSING › Chapter 19 - PHARMACISTS › Part 2 - EXAMINATIONS › Section 16.19.2.3 - STATUTORY AUTHORITY

Current through Register Vol. 35, No. 13, July 16, 2024
Section 61-11-9 NMSA 1978 establishes qualifications for licensure as a pharmacist by examination. Paragraph (2) of Subsection A of Section 61-11-6 NMSA 1978 requires that the board of pharmacy provide for examinations of applicants for licensure as pharmacists.
New Mexico Administrative Code › Title 16 - OCCUPATIONAL AND PROFESSIONAL LICENSING › Chapter 19 - PHARMACISTS › Part 2 - EXAMINATIONS › Section 16.19.2.6 - OBJECTIVE

Current through Register Vol. 35, No. 13, July 16, 2024
The objective of Part 2 of Chapter 19 is to identify candidate's qualifications and establish uniform criteria for obtaining licensure as a pharmacist by examination.
New Mexico Administrative Code › Title 16 - OCCUPATIONAL AND PROFESSIONAL LICENSING › Chapter 19 - PHARMACISTS › Part 2 - EXAMINATIONS › Section 16.19.2.7 - DEFINITIONS

Current through Register Vol. 35, No. 13, July 16, 2024
A.
"ACPE"
Accreditation Council for Pharmacy Education
B.
"FPGEE"
Foreign Pharmacy Graduate Equivalency Examination
C.
"MPJE"
Multistate Pharmacy Jurisprudence Examination
D.
"NABP"
National Association of Boards of Pharmacy
E.
"NAPLEX"
North American Pharmacist Licensure Examination
New Mexico Administrative Code › Title 16 - OCCUPATIONAL AND PROFESSIONAL LICENSING › Chapter 19 - PHARMACISTS › Part 2 - EXAMINATIONS › Section 16.19.2.8 - APPLICATIONS - SUBJECTS

Current through Register Vol. 35, No. 13, July 16, 2024
Applicants for licensure by examination shall pass the standard national examination currently known as the NAPLEX and pass the MPJE.
A.
EXAMINATIONS:
(1) In order to sit for the NAPLEX, the applicant must be a graduate from a college of pharmacy accredited by the ACPE.
(2) Candidates must achieve a score of passing as set by NABP to pass the NAPLEX.
(3) Candidates must achieve a score of passing as set by NABP to pass the MPJE.
(4) Candidates taking the NAPLEX in participating states may transfer scores in compliance with NABP "score transfer program", upon payment of the fee to the New Mexico board of pharmacy for licensure by examination, and in compliance with such other requirements set by the New Mexico board of pharmacy so long as New Mexico participates in the NABP "score transfer program."
(5) Only those score-transfer applicants who have passed the NAPLEX and received their score may take the MPJE.
New Mexico Administrative Code › Title 16 - OCCUPATIONAL AND PROFESSIONAL LICENSING › Chapter 19 - PHARMACISTS › Part 2 - EXAMINATIONS › Section 16.19.2.9 - EXAMINATION REPEATS

Current through Register Vol. 35, No. 13, July 16, 2024
A candidate who fails either the NAPLEX or MPJE may repeat that examination upon submittal of the proper application and fee. A candidate may not take either the NAPLEX or MPJE more than four consecutive times without passing, and the time limit is three years from the first exam attempt (respectively). Failure to finish an examination is counted as an attempt. Candidates who fail or do not complete the NAPLEX shall wait a period of at least 45 days prior to retaking the examination. Candidates who fail or do not complete the MPJE shall wait a period of at least 30 days prior to retaking the examination.
New Mexico Administrative Code › Title 16 - OCCUPATIONAL AND PROFESSIONAL LICENSING › Chapter 19 - PHARMACISTS › Part 2 - EXAMINATIONS › Section 16.19.2.11 - COMPLETION OF INTERNSHIP

Current through Register Vol. 35, No. 13, July 16, 2024
No applicant may be admitted to the examination until
				  completion of required internship has been certified by the
				  Board.
New Mexico Administrative Code › Title 16 - OCCUPATIONAL AND PROFESSIONAL LICENSING › Chapter 19 - PHARMACISTS › Part 2 - EXAMINATIONS › Section 16.19.2.12 - QUALIFICATIONS

Current through Register Vol. 35, No. 13, July 16, 2024
The board shall not recognize as sufficient qualifications
				  for licensure the diploma of any school or college of
				  pharmacy.
New Mexico Administrative Code › Title 16 - OCCUPATIONAL AND PROFESSIONAL LICENSING › Chapter 19 - PHARMACISTS › Part 2 - EXAMINATIONS › Section 16.19.2.13 - PHOTO REQUIRED

Current through Register Vol. 35, No. 13, July 16, 2024
Each applicant for licensure shall furnish a current photograph, head and shoulders only, approximately 3 x 4 inches.
New Mexico Administrative Code › Title 16 - OCCUPATIONAL AND PROFESSIONAL LICENSING › Chapter 19 - PHARMACISTS › Part 2 - EXAMINATIONS › Section 16.19.2.14 - REINSTATEMENT EXAMINATIONS

Current through Register Vol. 35, No. 13, July 16, 2024
A. The board may require an applicant for reinstatement of licensure, for any reason, including revocation, to make a passing score on any combination of the NAPLEX and MPJE.
B. The criteria for passing these examinations shall be the same as required by this regulation.
C. If a pharmacist has not been active in the area of pharmacy practice for greater than two years but less than six years, the pharmacist candidate shall complete the following:
(1) submit renewal form;
(2) pay past renewal fees and reinstatement fees;
(3) submit proof of continuing education for each inactive renewal period;
(4) submit proof of completed internship of minimum of 60 hours for each year of inactivity;
(5) sucessfully complete the MPJE; or
New Mexico Administrative Code › Title 16 - OCCUPATIONAL AND PROFESSIONAL LICENSING › Chapter 19 - PHARMACISTS › Part 3 - RECIPROCITY › Section 16.19.3.3 - STATUTORY AUTHORITY

Current through Register Vol. 35, No. 13, July 16, 2024
Section
				  61-11-10
				  NMSA 1978 authorizes the board of pharmacy to issue a certificate of licensure
				  as a pharmacist, with or without examination, by reciprocity.
New Mexico Administrative Code › Title 16 - OCCUPATIONAL AND PROFESSIONAL LICENSING › Chapter 19 - PHARMACISTS › Part 3 - RECIPROCITY › Section 16.19.3.5 - EFFECTIVE DATE

Current through Register Vol. 35, No. 13, July 16, 2024
February 15, 1996, unless a different date is cited at the
				  end of a Section or Paragraph. This Part reformatted for inclusion into the New
				  Mexico Administrative Code (NMAC) effective 2-15-96.
New Mexico Administrative Code › Title 16 - OCCUPATIONAL AND PROFESSIONAL LICENSING › Chapter 19 - PHARMACISTS › Part 3 - RECIPROCITY › Section 16.19.3.6 - OBJECTIVE

Current through Register Vol. 35, No. 13, July 16, 2024
The objective of Part 3 of Chapter 19 is to recognize
				  qualifications of pharmacists licensed by examination in other states that
				  grant reciprocal privileges in New Mexico and to establish uniform criteria for
				  obtaining licensure as a pharmacist by reciprocity.
New Mexico Administrative Code › Title 16 - OCCUPATIONAL AND PROFESSIONAL LICENSING › Chapter 19 - PHARMACISTS › Part 3 - RECIPROCITY › Section 16.19.3.8 - RECIPROCAL LICENSURE

Current through Register Vol. 35, No. 13, July 16, 2024
Reciprocal licensure shall be granted to those persons licensed by examination as a licensed pharmacist in other states or territories of the United States which grant reciprocal privileges to persons licensed as pharmacists by examination in New Mexico. An applicant must be a graduate of an approved college of pharmacy and have completed required intern training or have worked one year as a licensed pharmacist in the state in which the applicant has licensure by examination.
New Mexico Administrative Code › Title 16 - OCCUPATIONAL AND PROFESSIONAL LICENSING › Chapter 19 - PHARMACISTS › Part 3 - RECIPROCITY › Section 16.19.3.9 - APPLICANT INELIGIBLE

Current through Register Vol. 35, No. 13, July 16, 2024
A. An applicant shall be deemed to be ineligible to reciprocate if licensure in the state of examination is not current; or if the pharmacist has worked less than one year or internship requirements at the time of examination, did not meet New Mexico's internship requirements.
B. An applicant who qualifies for and acquired a license in a state that does not grant reciprocal privileges with New Mexico shall be deemed ineligible for reciprocal licensure.
New Mexico Administrative Code › Title 16 - OCCUPATIONAL AND PROFESSIONAL LICENSING › Chapter 19 - PHARMACISTS › Part 3 - RECIPROCITY › Section 16.19.3.10 - REINSTATEMENT OF RECIPROCITY LICENSE, ELIGIBLITY

Current through Register Vol. 35, No. 13, July 16, 2024
A. An applicant must have current pharmacist licensure in the state in which the applicant has licensed by examination.
B. If an applicant has not been active in the area of pharmacy practice for greater than two years but less than six years, the pharmacist candidate shall complete the following:
(1) submit renewal form;
(2) pay past renewal fees and reinstatement fees;
(3) submit proof of continuing education for each inactive renewal period;
(4) submit proof of completed internship a minimum of 60 hours for each year of inactivity;
(5) successfully complete the Multistate Pharmacy Jurisprudence Examination (MPJE); and
(6) submit a current letter of good standing from the state of examination.
New Mexico Administrative Code › Title 16 - OCCUPATIONAL AND PROFESSIONAL LICENSING › Chapter 19 - PHARMACISTS › Part 3 - RECIPROCITY › Section 16.19.3.11 - JURISPRUDENCE EXAMINATION

Current through Register Vol. 35, No. 13, July 16, 2024
A. An applicant for reciprocity will be required to submit all paperwork required for reciprocity, and take and pass the MPJE prior to issuance of a license.
B. Failure to take the MPJE within one year after the application is received shall nullify the application and a refund of fees will not be made.
C. Upon submittal of the proper application and fee, a candidate may repeat the MPJE. A candidate shall take the MPJE no more than four consecutive times without passing, and the time limit is three years from the first exam attempt. Failure to finish the examination is counted as an attempt. Candidates who fail or do not complete the MPJE shall wait a period of at least 30 days prior to retaking the examination.
New Mexico Administrative Code › Title 16 - OCCUPATIONAL AND PROFESSIONAL LICENSING › Chapter 19 - PHARMACISTS › Part 3 - RECIPROCITY › Section 16.19.3.12 - PHOTO REQUIRED

Current through Register Vol. 35, No. 13, July 16, 2024
Each applicant for licensure shall furnish a current photograph, head and shoulders only, approximately 3 x 4 inches.
New Mexico Administrative Code › Title 16 - OCCUPATIONAL AND PROFESSIONAL LICENSING › Chapter 19 - PHARMACISTS › Part 3 - RECIPROCITY › Section 16.19.3.13 - EVIDENCE OF QUALIFICATIONS

Current through Register Vol. 35, No. 13, July 16, 2024
The New Mexico board of pharmacy shall deem an applicant ineligible to be licensed by reciprocity if the application that they submit fails to furnish evidence:
A. that the license which applicant acquired by examination in the state from which they apply is in good standing;
B. that applicant completed the NAPLEX examination with a passing score;
C. that applicant is not addicted to the use of alcohol, narcotic or hypnotic drugs;
D. that the applicant has not been charged with, convicted, fined or had their license suspended or revoked for violation laws pursuant to the provisions of 16.19.4.8 NMAC.
New Mexico Administrative Code › Title 16 - OCCUPATIONAL AND PROFESSIONAL LICENSING › Chapter 19 - PHARMACISTS › Part 3 - RECIPROCITY › Section 16.19.3.14 - PENDING INDICTMENT OR ALLEGED VIOLATIONS

Current through Register Vol. 35, No. 13, July 16, 2024
An applicant may be ineligible for reciprocal licensure if there is pending an indictment or alleged violation of any law pursuant to the provisions of 16.19.4.8 NMAC.
New Mexico Administrative Code › Title 16 - OCCUPATIONAL AND PROFESSIONAL LICENSING › Chapter 19 - PHARMACISTS › Part 3 - RECIPROCITY › Section 16.19.3.15 - EXPEDITED LICENSE

Current through Register Vol. 35, No. 13, July 16, 2024
A. Definitions as used in this section.
(1)
"expedited license"
is a one-year provisional license that confers the same rights, privileges and responsibilities as a regular license issued by the board;
(2)
"military service member"
means a person who is:
(a) serving in the armed forces of the United States as an active duty member, or in an active reserve component of the armed forces of the United States, including the national guard;
(b) the spouse of a person who is serving in the armed forces of the United States or in an active reserve component of the armed forces of the United States, including the national guard, or a surviving spouse of a member who at the time of the member's death was serving on active duty; or
(c) the child of a military service member if the child is also a dependent of that person for federal income tax purposes.
(3)
"veteran"
means a person who has received an honorable discharge or separation from military service of the United States.
New Mexico Administrative Code › Title 16 - OCCUPATIONAL AND PROFESSIONAL LICENSING › Chapter 19 - PHARMACISTS › Part 3 - RECIPROCITY › Section 16.19.3.16 - PORTABILITY OF PHARMACIST LICENSE, SERVICE MEMBERS AND SPOUSES

Current through Register Vol. 35, No. 13, July 16, 2024
Service members, as defined in 50 USC §
										3911, and their spouses who relocate residency to New Mexico because of military orders for military service, may apply for and be issued a provisional pharmacist license by reciprocity, without taking the NM MPJE, during the duration of such military orders if the:
A. license is in good standing with the authority that issued it;
B. license was actively used during the two years immediately preceding the relocation;
C. applicant meets the requirements of this part and completes the NABP application for pharmacist license by reciprocity and submits an application for pharmacist license by reciprocity to the board;
D. applicant provides documentation of eligibility and a copy of such military orders to the board;
E. applicant remains in good standing with:
(1) the licensing authority that issued the covered license; and
(2) every other licensing authority that has issued to the service member or the spouse of a service member a pharmacist license;
New Mexico Administrative Code › Title 16 - OCCUPATIONAL AND PROFESSIONAL LICENSING › Chapter 19 - PHARMACISTS › Part 4 - PHARMACIST › Section 16.19.4.3 - STATUTORY AUTHORITY

Current through Register Vol. 35, No. 13, July 16, 2024
Paragraph (1) of Subsection A of Section
				  61-11-6 NMSA, 1978 authorizes the
				  board of pharmacy to adopt, regularly review and revise rules and regulations
				  necessary to carry out the provisions of the Pharmacy Act, Sections
				  61-11-1,
				  61-11-2,
				  61-11-4 to
				  61-11-28 NMSA 1978. Those
				  provisions include the authority to:
A. deny or take disciplinary action with
				respect to any certificate of registration or license held or applied for under
				the Pharmacy Act, Section
				61-11-20 NMSA 1978;
B. require and establish criteria for
				continuing education as a condition of renewal of a pharmacist license,
				Paragraph (4) of Subsection A of Section
				61-11-6 NMSA 1978;
C. issue permits or licenses, as defined and
				limited by board regulation, to nursing homes, industrial and public health
				clinics and home care services, Paragraph (6) of Subsection A of Section
				61-11-6 and
				61-11-14 NMSA 1978;
D. provide for the issuance and renewal of
				licenses for pharmacists, Paragraph (3) of Subsection A of Section
				61-11-6, and
				61-11-13 NMSA 1978;
E. provide for the registration of pharmacist
				interns, their certification, annual renewal of certification, training,
				supervision, and discipline, Paragraph (5) of Subsection A of Section
				61-11-6 NMSA 1978; and
F. adopt rules and regulations that establish
				patient counseling requirements, Paragraph (18) of Subsection A of 61-11-6 NMSA
				1978. Under the Pharmacist Prescriptive Authority Act, Sections
				61-11B-1 to
				61-11B-3 NMSA 1978, the board is
				required to establish regulations governing certification as a pharmacist
				clinician. The Impaired Pharmacists Act, Sections
				61-11A-1 to
				61-11A-8 NMSA 1978, requires the
				establishment by the board of a plan for treatment and rehabilitation of
				impaired pharmacists. Subsection B of Section 61-1-36 NMSA 1978 authorizes the
				board of pharmacy to promulgate rules relating to listing specific criminal
				convictions that could disqualify an applicant from receiving a license on the
				basis of a previous felony conviction. Subsection B of Section
				28-2-3 NMSA 1978 prohibits the
				board of pharmacy from considering certain criminal records to be used,
				distributed or disseminated in connection with an application for a license.
				Section 28-2-4 NMSA 1978 authorizes the
				board of pharmacy the power to refuse to grant or renew, or suspend or revoke a
				license where the applicant or licensee has been convicted of a felony and the
				criminal conviction directly relates to the particular profession and other
				convictions specified.
New Mexico Administrative Code › Title 16 - OCCUPATIONAL AND PROFESSIONAL LICENSING › Chapter 19 - PHARMACISTS › Part 4 - PHARMACIST › Section 16.19.4.5 - EFFECTIVE DATE

Current through Register Vol. 35, No. 13, July 16, 2024
February 15, 1996, unless a different date is cited at the
				  end of a Section or Paragraph. This Part reformatted for inclusion into the New
				  Mexico Administrative Code (NMAC) effective 2-15-96.
New Mexico Administrative Code › Title 16 - OCCUPATIONAL AND PROFESSIONAL LICENSING › Chapter 19 - PHARMACISTS › Part 4 - PHARMACIST › Section 16.19.4.6 - OBJECTIVE

Current through Register Vol. 35, No. 13, July 16, 2024
The objective of Part 4 of Chapter 19 is to promote the
				  delivery of quality pharmaceutical services by establishing comprehensive
				  regulations governing pharmacists, conduct, continuing education and
				  requirements, criteria for specialized certification, and duties and
				  responsibilities.
New Mexico Administrative Code › Title 16 - OCCUPATIONAL AND PROFESSIONAL LICENSING › Chapter 19 - PHARMACISTS › Part 4 - PHARMACIST › Section 16.19.4.10 - CONTINUING PHARMACY EDUCATION REQUIREMENTS

Current through Register Vol. 35, No. 13, July 16, 2024
A. Continuing pharmacy education (CPE) shall include study in one or more of the general areas of socioeconomic and legal aspects of health care; the properties and actions of drugs and dosage forms; etiology; characteristics and therapeutics of the disease state, or such other subjects as the board may from time to time approve. Continuing pharmacy education approved in New Mexico shall be limited to programs and activities offered by the accreditation council for pharmacy education (ACPE), accredited provider, programs or courses approved by the board or other state boards of pharmacy and pharmacy law programs offered by the board.
B. Continuing pharmacy education, certified as completed by an approved provider will be required of a registered pharmacist who applies for renewal of New Mexico registration as follows: 3.0 CEU (30 contact hours) every two years. Effective January 1, 2013, pharmacist and pharmacist clinician renewal applications shall document.
(1) A minimum of 1.0 CEU (10 contact hours) excluding the law requirement, per renewal period shall be obtained through "live programs" that are approved as such by the ACPE or the accreditation council for continuing medical education (ACCME). Live programs provided by other providers (such as continuing nursing education) may be acceptable based on review and approval of the board.
(2) A minimum of 0.2 CEU (two contact hours) per renewal period shall be in the area of patient safety as applicable to the practice of pharmacy.
(3) A minimum of 0.2 CEU (two contact hours) per renewal period shall be in the subject area of pharmacy law offered by the New Mexico board of pharmacy.
(4) Effective January 1, 2015, a minimum of 0.2 CEU (two contact hours) per renewal period shall be in the area of safe and appropriate use of opioids. An educational program consisting of a minimum of 0.2 CEU (2 contact hours) that addresses both patient safety as applicable to the practice of pharmacy and the safe and appropriate use of opioids will satisfy requirements of Paragraphs (2) and (4) of Subsection B of this section.
New Mexico Administrative Code › Title 16 - OCCUPATIONAL AND PROFESSIONAL LICENSING › Chapter 19 - PHARMACISTS › Part 4 - PHARMACIST › Section 16.19.4.11 - CONSULTANT PHARMACIST

Current through Register Vol. 35, No. 13, July 16, 2024
A.
Duties and responsibilities:
(1) To abide by the code of ethics of the
American Society of Consultant Pharmacists
. Must be qualified to practice as a consultant pharmacist and is to be aware of all federal and state drug laws, rules and regulations related to pharmacy services, and to provide the facility with current information pertaining to drug service.
(2) Ensure that drugs are handled in the facility in which he/she is the consultant pharmacist, in a manner that protects the safety and welfare of the patient.
(3) Set the policies and procedures in the facility as related to all facets of drug handling and distribution; these policies and procedures to be reviewed and updated on an annual basis.
(4) To visit the facility, commensurate with their duties, as specified by board regulations relative to the facility or by written contract with the administration of the facility not inconsistent with board regulations.
(5) His/her primary goal and objective shall be the health and safety of the patient, and he/she shall make every effort to assure the maximum level of safety and efficacy in the provision of pharmaceutical services.
(6) The consultant pharmacist shall not condone or participate in any transaction with any practitioner of another health profession, or any other persons whosoever under which fees are divided, or rebates or kickbacks paid or caused to be paid, or which may result in financial exploitation of patients or their families in connection with the provision of drugs and medication or supplies or pharmaceutical services.